Insufficient sleep costs the United States up to $411 billion every year — about 2.28% of GDP — according to RAND Europe's Why Sleep Matters (2016). Across five advanced economies, the combined annual loss exceeds $680 billion.
Drowsy driving alone costs $109 billion a year (NHTSA). Undiagnosed obstructive sleep apnea costs another $149.6 billion (AASM/Frost & Sullivan, 2016). Major depressive disorder — heavily comorbid with insomnia — adds $326.2 billion to the US economic burden (2018).
Meanwhile, the average US household spends roughly $224 a year on bedding (BLS Consumer Expenditure Survey) — a fraction of the $2,280 in productivity each insomniac worker loses annually (Kessler/Hillman, Sleep, 2011). Every figure on this page traces to a primary source.
Researched and compiled by the Or & Zon editorial team — drawing on primary sources from RAND Europe, NHTSA, AAA Foundation, AASM, the National Safety Council, CDC, BLS, AAFA, and peer-reviewed sleep journals. Every claim links to its original report.
Last updated: May 2026 · Reading time: 16 min · Data points: 50+ across 26 sources
📋 Key Takeaways
- The United States loses up to $411 billion a year — 2.28% of GDP — to insufficient sleep (RAND Europe, Why Sleep Matters 2016).
- Across five advanced economies (US, Japan, Germany, UK, Canada), the combined annual GDP loss exceeds $680 billion (RAND Europe, 2016).
- Chronic insomnia costs each affected worker an average of 14 absent days plus 30 unproductive days per year (RAND Europe, Societal and Economic Burden of Insomnia in Adults 2023).
- Drowsy driving causes about 91,000 crashes, 50,000 injuries, and 800 fatalities annually in the US, at a societal cost of $109 billion (NHTSA).
- Undiagnosed obstructive sleep apnea costs the US $149.6 billion a year, with 29.4 million adults affected (AASM/Frost & Sullivan, Hidden Health Crisis 2016).
- Direct healthcare spending on sleep disorders reached $94.9 billion a year, with each diagnosed patient adding $7,000 in annual incremental cost (Journal of Clinical Sleep Medicine, 2021).
- US asthma — heavily linked to bedroom allergens — costs $56 to $82 billion a year; 84.2% of US homes contain detectable dust mite allergen (AAFA; J. Allergy Clin. Immunol., 2002).
- The average US consumer unit spends just $224 a year on bedding (~$143 mattresses + $80.53 bedroom linens) (BLS Consumer Expenditure Survey, 2022).
- A new mattress reduced back pain by 63% and improved sleep quality by 55% in a 28-day clinical trial (Jacobson et al., Journal of Chiropractic Medicine, 2008–09).
- Workplace mental-health programs return $4 for every $1 invested (Deloitte).
1. The $680 Billion Scoreboard: GDP Loss by Country
RAND Europe quantified what governments politely ignore: sleep deprivation as a measurable tax on national output. Japan's 2.92% GDP hit makes it the most sleep-strained advanced economy in the dataset — the consequence of a long-hours work culture meeting an entire generation of insufficient rest. The United States loses roughly $411 billion every year, an amount that exceeds the entire annual federal budget for elementary and secondary education.
| Metric | Value | Source |
|---|---|---|
| United States — annual GDP loss to insufficient sleep | Up to $411 billion / 2.28% of GDP | RAND Europe, Why Sleep Matters 2016 |
| Japan — annual GDP loss | $138 billion / 2.92% of GDP | RAND Europe, Why Sleep Matters 2016 |
| Germany — annual GDP loss | $60 billion / 1.56% of GDP | RAND Europe, Why Sleep Matters 2016 |
| United Kingdom — annual GDP loss | $50 billion / 1.86% of GDP | RAND Europe, Why Sleep Matters 2016 |
| Canada — annual GDP loss | $21.4 billion / 1.35% of GDP | RAND Europe, Why Sleep Matters 2016 |
| Five-country combined loss | Greater than $680 billion / yr | RAND Europe, Why Sleep Matters 2016 |
| US working days lost annually to insufficient sleep | ~1.2 million | RAND Europe, Why Sleep Matters 2016 |
| Potential US GDP gain if <6-hr sleepers reached 6–7 hrs | +$226.4 billion / yr | RAND Europe, Why Sleep Matters 2016 |
RAND Europe 2016 remains the most recent comprehensive cross-country dataset for the macroeconomic cost of insufficient sleep. Read the full report: RAND Europe — Why Sleep Matters: Quantifying the Economic Costs of Insufficient Sleep.
2. Workplace Productivity, Absenteeism, and Presenteeism
Presenteeism — showing up for work too tired to function — costs employers far more than absenteeism, and most companies don't measure it. The National Safety Council estimates that each 1,000 employees costs an employer about $1 million a year in fatigue-related losses, with three quarters of that bill coming from people who are physically present but cognitively absent.
| Metric | Value | Source |
|---|---|---|
| US employer fatigue cost — annual total | ~$136 billion | National Safety Council, Cost of Fatigue at Work |
| Cost per 1,000 employees per year | ~$1 million ($272K absenteeism + $776K presenteeism) | National Safety Council, Cost of Fatigue at Work |
| US insomnia cost to employers | $63.2 billion / yr | Kessler & Hillman, Sleep 2011 |
| Productivity loss per insomniac worker | 11.3 days / $2,280 / yr | Kessler & Hillman, Sleep 2011 |
| Days lost per chronic-insomnia worker | 14 absent + 30 unproductive / yr | RAND Europe, Insomnia Burden 2023 |
| US economic drag from chronic insomnia | Greater than $200 billion / yr | RAND Europe, Insomnia Burden 2023 |
| Poor-sleep workers — annual employer cost | ~$44 billion | Gallup, Poor Sleep poll 2022 |
| Total US worker-illness absenteeism cost | $225.8 billion / yr ($1,685 per employee) | CDC Foundation, Worker Illness and Injury Costs 2015 |
Read the canonical employer-fatigue analysis: National Safety Council — The Real Cost of Fatigue at Work.

3. Drowsy Driving and Fatigue-Related Accidents
Police-report figures wildly understate the road toll because officers rarely log fatigue as a contributing factor at the scene. AAA Foundation's naturalistic-driving analysis — which uses in-cabin cameras to verify driver state — found that drowsy drivers were involved in 17.6% of US fatal crashes between 2017 and 2021, roughly 5,967 deaths a year. NHTSA's police-report-only figure for the same period sits near 684 deaths. Both numbers are real; the gap is documented underreporting.
| Metric | Value | Source |
|---|---|---|
| US drowsy-driving crashes per year | ~91,000 | NHTSA, Drowsy Driving |
| Annual injuries — drowsy driving | ~50,000 | NHTSA, Drowsy Driving |
| Annual fatalities (police-reported) | ~684–800 (2021: 684 / 1.6% of all motor-vehicle deaths) | NHTSA FARS 2021 |
| Societal cost — drowsy driving | $109 billion / yr | NHTSA, Drowsy Driving |
| Share of fatal crashes involving drowsy drivers (camera-verified) | 17.6% (~5,967 deaths / yr) | AAA Foundation, Drowsy Driving in Fatal Crashes 2017–2021 |
| Commercial truckers — relative risk of fatigue-related crash | ~4× higher than non-fatigued drivers | FMCSA / NIOSH driver-fatigue research |
| Commercial-trucking fatigue-crash cost | ~$20 billion / yr | FMCSA / NIOSH |
Read the AAA Foundation methodology that uses naturalistic-driving cameras to verify drowsiness: AAA Foundation — Drowsy Driving in Fatal Crashes 2017–2021.
4. The Sleep Apnea and Sleep-Disorder Healthcare Bill
Undiagnosed obstructive sleep apnea is a $100 billion savings opportunity hiding behind unbilled CPAP scripts. AASM and Frost & Sullivan estimated that 29.4 million US adults — roughly 12% of the adult population — have OSA, the majority undiagnosed. Treating every OSA case would save the US economy more than $100 billion a year. The 2016 figure remains the most recent comprehensive estimate; downstream peer-reviewed work has confirmed the order of magnitude.
| Metric | Value | Source |
|---|---|---|
| Cost of undiagnosed OSA — US | $149.6 billion / yr | AASM / Frost & Sullivan, Hidden Health Crisis 2016 |
| Breakdown — lost productivity | $86.9 billion / yr | AASM / Frost & Sullivan 2016 |
| Breakdown — motor-vehicle accidents | $26.2 billion / yr | AASM / Frost & Sullivan 2016 |
| Breakdown — workplace accidents | $6.5 billion / yr | AASM / Frost & Sullivan 2016 |
| Breakdown — comorbid conditions | $30 billion / yr | AASM / Frost & Sullivan 2016 |
| US adults with OSA | 29.4 million (~12% of adults) | AASM / Frost & Sullivan 2016 |
| Annual savings if all OSA were diagnosed and treated | $100.1 billion / yr | AASM / Frost & Sullivan 2016 |
| Direct US healthcare cost — all sleep disorders | $94.9 billion / yr | J. Clinical Sleep Medicine 2021 |
| Incremental healthcare per diagnosed sleep-disorder patient | +$7,000 / yr | J. Clinical Sleep Medicine 2021 |
| CPAP — net cost-effectiveness benefit per patient | $13,024 net benefit | Sleep Medicine Reviews 2024 |
Read the original AASM commission: AASM — Economic Impact of Obstructive Sleep Apnea.

5. Mental Health, Cardiovascular, and Obesity Comorbidity Costs
Poor sleep doesn't sit on its own line item — it shows up on the depression, cardiovascular, and obesity bills. The economic burden of major depressive disorder reached $326.2 billion in 2018, up 37.9% since 2010, and patients with comorbid insomnia add roughly $5,800 per year on top of MDD-only treatment costs. Eighteen percent of US adults sleep less than six hours a night — about 53 million people moving through the day with cumulative biological debt.
| Metric | Value | Source |
|---|---|---|
| Major depressive disorder — US economic burden | $326.2 billion (2018, +37.9% since 2010) | PharmacoEconomics / Greenberg et al. 2021 |
| Chronic insomnia — relative risk of major depression | Up to ~40× higher than non-insomniacs | PMC depression-insomnia comorbidity reviews |
| Annual cost uplift — MDD with insomnia vs MDD alone (commercial) | +$5,842 / yr | Asami et al. (commercial-claims comorbidity analysis) |
| Annual cost uplift — MDD with insomnia vs MDD alone (Medicaid) | +$5,152 / yr | Asami et al. (Medicaid-claims comorbidity analysis) |
| Total social cost of insomnia (incl. comorbidities) | ~$160 billion / yr | Hillman / Deloitte Australia 2018 (extrapolated) |
| Sleep deprivation — relative risk of cardiovascular disease | RR 1.09 (meta-analysis 2023) | CVD meta-analysis (NIH/PMC) 2023 |
| US cardiovascular healthcare spend | Greater than $300 billion / yr (~13% of total health spend) | AHA / NIH cost-of-illness studies |
| US obesity-related medical costs | $260.6 billion / yr | CDC / NIH (Cawley et al. 2021) |
| US adults sleeping under 6 hours nightly | ~18% (~53 million) | CDC BRFSS 2022 |
For the canonical comorbidity-cost dataset see the published abstract: Greenberg et al., The Economic Burden of Adults With Major Depressive Disorder (PharmacoEconomics, 2021). The sleep environment is one of the lowest-friction levers for adults trying to break the insomnia–depression loop — start with the basics in our organic duvet covers collection.
— Or & Zon —
Shop Organic Bedding
The full Or & Zon edit · GOTS-certified organic cotton & stonewashed linen · made in Portugal.
6. The Bedroom That's Making Us Sick: Allergens and Asthma
Bedding is the most concentrated allergen surface in the home. Dust mites (Dermatophagoides) colonize pillows, mattresses, and bedcovers, feed on shed human skin, and reach peak airway exposure during the eight hours a face is pressed into a pillow. The First National Survey of Lead and Allergens in Housing (NIH/JACI 2002) — still the most recent comprehensive bedroom-allergen prevalence dataset — found detectable dust mite allergen in 84.2% of US homes, with nearly a quarter at asthma-trigger levels.
| Metric | Value | Source |
|---|---|---|
| US asthma — total annual economic cost | $56–82 billion / yr | AAFA, Cost of Asthma |
| Annual asthma medical cost per person | $3,266 | AAFA, Cost of Asthma |
| Asthma — missed work and school | ~$3 billion / yr (8.7M workdays + 5.2M school days) | AAFA, Cost of Asthma |
| US homes with detectable dust mite allergen | 84.2% | J. Allergy Clin. Immunol. 2002 |
| US homes — sensitization-relevant levels (≥2 µg/g) | 46.2% | J. Allergy Clin. Immunol. 2002 |
| US homes — asthma-trigger levels (≥10 µg/g) | 24.2% | J. Allergy Clin. Immunol. 2002 |
| Industrialized populations — dust mite allergy prevalence | ~40% | NIH / NIAID dust mite reference |
| Allergic asthmatics — share HDM-sensitized | Up to 90% | NIH / allergy clinical reviews |
Read the AAFA economic dataset on US asthma costs: AAFA — Cost of Asthma on Society. Note: allergen-reduction bedding is associated with reduced exposure rather than proven to lower asthma medical costs in randomized trials. For a primer on the bedding side of the equation, browse our organic bedding collection.
7. The Sleep Economy and the ROI of Better Bedding
The average US household spends roughly $224 a year on bedding while a single bad year of sleep costs the typical insomniac worker $2,280 in lost productivity — the math on upgrading is almost embarrassing. The most rigorous bedding-upgrade trial available — Jacobson et al. (2008–09) — reported a 63% reduction in back pain and a 55% improvement in sleep quality after 28 days on a new mattress. It is a single-arm, short-duration study, the strongest available evidence in this category but not a replacement for a randomized controlled trial.
| Metric | Value | Source |
|---|---|---|
| Global sleep economy | ~$432B (2019) → ~$585B (2024) | Statista / Frost & Sullivan |
| Global mattress market | $57.5B (2025) → $82.6B (2033) | Fortune Business Insights |
| US household bedding spend per year | ~$224 ($143 mattresses + $80.53 bedroom linens) | BLS Consumer Expenditure Survey 2022 |
| Mean US mattress replacement cycle | 8.3 years (2022) | ISPA / Better Sleep Council |
| Mattress upgrade — back-pain reduction (28-day trial) | 63% | Jacobson et al., J. Chiropractic Medicine 2008–09 |
| Mattress upgrade — shoulder-pain reduction | 64% | Jacobson et al. 2008–09 |
| Mattress upgrade — sleep-quality improvement | 55% | Jacobson et al. 2008–09 |
| Mattress upgrade — perceived stress drop | ~20% | Jacobson et al. 2008–09 |
| Workplace mental-health programs — ROI | $4 returned per $1 invested | Deloitte |
| Global value potential — employee health investment | $11.7 trillion | McKinsey Health Institute |
Jacobson et al. (2008–09) remains the canonical bedding-RCT citation despite its single-arm, 28-day design. Read the abstract: Jacobson et al., Journal of Chiropractic Medicine, 2009. If you're treating bedding as a personal-finance line item, our guide to choosing organic bedding walks through what's actually worth paying for.
📊 Summary: Sleep Statistics 2026 by the Numbers
| Metric | Value | Source |
|---|---|---|
| US annual loss to insufficient sleep | $411 billion / 2.28% of GDP | RAND Europe 2016 |
| Japan annual loss | $138 billion / 2.92% of GDP | RAND Europe 2016 |
| RAND-5 combined annual loss | Greater than $680 billion | RAND Europe 2016 |
| US chronic-insomnia drag | Greater than $200 billion / yr | RAND Europe 2023 |
| US employer fatigue cost | $136 billion / yr ($1M per 1,000 employees) | National Safety Council |
| Insomnia worker productivity loss | $63.2B / yr ($2,280 per worker) | Kessler & Hillman 2011 |
| Drowsy-driving societal cost | $109B / yr (91,000 crashes) | NHTSA |
| Drowsy-driving fatalities (camera-verified) | ~5,967 / yr | AAA Foundation 2017–2021 |
| Cost of undiagnosed OSA | $149.6B / yr (29.4M adults) | AASM / Frost & Sullivan 2016 |
| Sleep-disorder healthcare spend | $94.9B / yr (+$7,000 per patient) | J. Clinical Sleep Medicine 2021 |
| Major depressive disorder — US burden | $326.2B (2018) | Greenberg et al. 2021 |
| MDD with insomnia — annual cost uplift | +$5,842 (commercial) | Asami et al. claims analysis |
| US cardiovascular healthcare spend | Greater than $300B / yr | AHA / NIH |
| US obesity-related medical costs | $260.6B / yr | CDC / Cawley et al. 2021 |
| US asthma annual cost | $56–82B / yr | AAFA |
| US homes with detectable dust mite allergen | 84.2% | JACI 2002 |
| US household bedding spend | ~$224 / yr | BLS CES 2022 |
| US mattress replacement cycle | 8.3 years | ISPA / Better Sleep Council 2022 |
| Mattress upgrade — back-pain reduction | 63% (28-day trial) | Jacobson et al. 2008–09 |
| Workplace mental-health ROI | $4 per $1 invested | Deloitte |
| Global employee-health value potential | $11.7 trillion | McKinsey Health Institute |
| Global sleep economy | ~$585B (2024) | Statista / Frost & Sullivan |
| Drowsy-driving share of fatal crashes (camera-verified) | 17.6% | AAA Foundation 2017–2021 |
| Annual savings if all OSA were diagnosed and treated | $100.1 billion / yr | AASM / Frost & Sullivan 2016 |
| Chronic insomniacs — relative risk of major depression | Up to ~40× | PMC depression-insomnia reviews |
| US adults sleeping under 6 hours nightly | ~18% (~53 million) | CDC BRFSS 2022 |
📚 Methodology and Sources
Every figure on this page traces to a primary source. Tier 1 evidence (government statistics, peer-reviewed journals, RAND Europe) is preferred; Tier 2 (industry analysts with disclosed methodology — Statista, Frost & Sullivan, Fortune Business Insights, Deloitte) is used only where Tier 1 data is unavailable. We never cite an SEO blog quoting a study. Where sources disagree (notably the AAA Foundation vs NHTSA drowsy-driving fatality count), we cite both and explain the methodological gap.
- RAND Europe — Why Sleep Matters: Quantifying the Economic Costs of Insufficient Sleep (RR-1791, 2016)
- RAND Europe — The Societal and Economic Burden of Insomnia in Adults (RR-A2166-1, 2023)
- NHTSA — Drowsy Driving
- AAA Foundation for Traffic Safety — Drowsy Driving in Fatal Crashes 2017–2021
- FMCSA / NIOSH — commercial driver fatigue research
- AASM / Frost & Sullivan — Hidden Health Crisis Costing America Billions (2016)
- Journal of Clinical Sleep Medicine — cost of sleep disorders (2021)
- Sleep Medicine Reviews — CPAP cost-effectiveness meta-analysis (2024)
- Sleep — Kessler & Hillman, insomnia and workplace productivity (2011, PMID 20042880)
- National Safety Council — Cost of Fatigue at Work
- CDC Foundation — Worker Illness and Injury Costs (2015)
- CDC BRFSS — short-sleep prevalence (2022)
- National Sleep Foundation — Sleep in America Poll (2025)
- Gallup — Poor Sleep poll (2022)
- AAFA — Cost of Asthma on Society
- Journal of Allergy and Clinical Immunology — First National Survey of Lead and Allergens in Housing (2002)
- PMC — depression-insomnia comorbidity reviews
- AHA / NIH — cardiovascular and obesity cost-of-illness studies
- BLS — Consumer Expenditure Survey (2022)
- ISPA / Better Sleep Council — mattress replacement data
- Statista / Frost & Sullivan — global sleep economy
- Fortune Business Insights — global mattress market
- Journal of Chiropractic Medicine — Jacobson et al. (2008–09)
- Hillman / Deloitte Australia — Cost of inadequate sleep (2018)
- Deloitte — workplace mental-health ROI
- McKinsey Health Institute — employee-health value potential
Last updated: May 2026. We update this page quarterly. Spotted a stale figure? Email us at hello@orezon.co and we will verify or replace it.
— Or & Zon —
Ready to upgrade to organic?
Or & Zon's full GOTS-certified edit — organic cotton percale, sateen, and stonewashed French linen. Sheets, duvet covers, pillowcases. Hand-finished in Portugal.
Comments